Categories: News

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NEW YORK, Sept. 4, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on September 4th

  • Stocks are fractionally higher Thursday morning after the S&P 500 rose about half a percentage point on Wednesday. Gains in shares of Big Tech including Alphabet and Apple fueled the rise.
  • A read of private sector payrolls today is expected to show 75,000 jobs were added last month. It precedes the non-farm payrolls report on Friday. Economists anticipate unemployment ticked higher in August to 4.3%.
  • Private Biotech firm Enveda announced its reached unicorn status. The clinical stage company is looking at a valuation of more than a billion dollars after closing its latest round of funding.

Opening Bell
Vontobel Asset Management celebrates its entry into the active ETF market with the launch of the Vontobel International Equity Active ETF (NYSE: VNIE)

Closing Bell
Fast Company celebrates the 30th anniversary of the Fast Company Innovation Festival

Click here to download the NYSE TV App

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update–biotech-enveda-raises-150-million-to-reach-unicorn-status-302546559.html

SOURCE New York Stock Exchange

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

5 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

5 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

5 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

5 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

5 hours ago